Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma
Clinical trial NCT05954897 · RECRUITING
Trial details
- NCT number
- NCT05954897
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-01-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.